Are you Dr. Oliver?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6411 Fannin St
Houston, TX 77030Phone+1 713-704-4000Fax+1 713-500-5484
Summary
- Dr. Dwight Oliver, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with William P. Clements, Jr. University Hospital and is an Associate Professor at University of Texas Southwestern Medical Center.
Education & Training
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1998 - 1999
- University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1995 - 1998
- Baylor College of MedicineResidency, Internal Medicine, 1994 - 1995
- Baylor College of MedicineInternship, Transitional Year, 1993 - 1994
- The University of Texas Health Science Center at San AntonioClass of 1993
Certifications & Licensure
- TX State Medical License 1984 - 2025
- PA State Medical License 1983 - 1988
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- Recurrent cytogenetic abnormalities reveal alterations that promote progression and transformation in myelodysplastic syndrome.Rolando García, Tasnim Alkayyali, Luis Mosquera Gomez, Carter Wright, Weina Chen
Cancer Genetics. 2024-11-01 - Comparison of 2 T-Cell Receptor-γ Clonality Assays on Skin Biopsies Suspicious for Mycosis Fungoides.Stan Miller, Travis Vandergriff, Heather Woodworth Goff, Jing Xu, Dwight Oliver
The American Journal of Dermatopathology. 2024-09-01 - 1 citationsSerum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predictmutation in acute myeloid leukemia.Chelsea Zhang, Andrew Chu, Richard Boriack, Robert Collins, Jing Xu
Ejhaem. 2023-08-01
Press Mentions
- Labs Face Challenges Creating Diagnosis Testing for COVID-19March 12th, 2020